
Sign up to save your podcasts
Or


Dr Fontanarosa provides summary and commentary on the April 18, 2012 issue of JAMA, the Journal of the American Medical Association. Bevacizumab and Non–Small Cell Lung Cancer Survival, Helicopter vs Ground EMS and Trauma Survival, Radiation Therapy Choices and Prostate Cancer Morbidity, Survival After Open vs Endovascular Repair of AAA, Survival After Partial vs Radical Nephrectomy, Setting PCORI's priorities, Changes to research regulations.
By JAMA Network3.9
127127 ratings
Dr Fontanarosa provides summary and commentary on the April 18, 2012 issue of JAMA, the Journal of the American Medical Association. Bevacizumab and Non–Small Cell Lung Cancer Survival, Helicopter vs Ground EMS and Trauma Survival, Radiation Therapy Choices and Prostate Cancer Morbidity, Survival After Open vs Endovascular Repair of AAA, Survival After Partial vs Radical Nephrectomy, Setting PCORI's priorities, Changes to research regulations.

320 Listeners

542 Listeners

705 Listeners

506 Listeners

302 Listeners

259 Listeners

894 Listeners

3,365 Listeners

1,149 Listeners

92 Listeners

516 Listeners

375 Listeners

257 Listeners

441 Listeners

270 Listeners